|

Nucresiran Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ALN-TTRSC04

Pipeline

Phase 3: 1

Top Sponsors

  • Alnylam Pharmaceuticals1

Indications

  • Transthyretin Amyloidosis With Cardiomyopathy1
  • Heart Disease1

La Jolla, California1 trial

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Clinical Trial Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.